|
0.15% POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.30% SODIUM CHLORIDE INJECTION · 300 MG per 100 ML + 150 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931741Code de médicament DPD
13034
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.20% SODIUM CHLORIDE INJECTION USP · 150 MG per 100 ML + 200 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01931598Code de médicament DPD
21753
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.33% SODIUM CHLORIDE INJECTION USP · 330 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · LIQUID
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931601Code de médicament DPD
21754
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION · 450 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931547Code de médicament DPD
18991
|
|
0.15% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION · 900 MG per 100 ML + 5 G per 100 ML + 150 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931644Code de médicament DPD
21755
|
|
0.30% POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION · 300 MG per 100 ML + 450 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01931571Code de médicament DPD
21752
|
|
0.45% SODIUM CHLORIDE INJECTION USP · 4.5 MG per ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01927949Code de médicament DPD
14579
|
|
0.9% SODIUM CHLORIDE INJECTION · SINGLE-USE · 900 MG per 100 ML · SOLUTION
|
FRESENIUS KABI CANADA LTD |
authorised |
DIN
02395150Code de médicament DPD
88027
|
|
0.9% SODIUM CHLORIDE INJECTION, USP · 0.9 G per 100 ML + 1 L per L · LIQUID
|
ABBOTT LABORATORIES, LIMITED |
cancelled |
DIN
02239576Code de médicament DPD
63054
|
|
0.9% SODIUM CHLORIDE INJECTION USP · 0.9 % · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01924303Code de médicament DPD
12185
|
|
0.9% SODIUM CHLORIDE INJECTION, USP · 0.9 % · SOLUTION
|
LABORATORIOS GRIFOLS S.A. |
authorised |
DIN
02533537Code de médicament DPD
102252
|
|
0.9% SODIUM CHLORIDE INJECTION, USP · 900 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00060208Code de médicament DPD
10040
|
|
0.9% SODIUM CHLORIDE INJECTION USP · 9 MG per ML · SOLUTION
|
OMEGA LABORATORIES LIMITED |
authorised |
DIN
02150204Code de médicament DPD
18136
|
|
0.9% SODIUM CHLORIDE INJECTION USP · SINGLE-USE · 9 MG per ML · SOLUTION
|
HIKMA CANADA LIMITED |
authorised |
DIN
02304341Code de médicament DPD
78963
|
|
0.9% SODIUM CHLORIDE INJECTION, USP · SINGLE-USE VIAL · 9 MG per ML · SOLUTION
|
JUNO PHARMACEUTICALS CORP. |
cancelled |
DIN
02538903Code de médicament DPD
102758
|
|
0.9% SODIUM CHLORIDE IRRIGATION, USP · 900 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00786160Code de médicament DPD
9825
|
|
0.9% SODIUM CHLORIDE IRRIGATION USP · FLEXIBLE PLASTIC CONTAINER (TITAN) · 0.9 % · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
02530600Code de médicament DPD
101977
|
|
0.9% SODIUM CHLORIDE IRRIGATION USP · HARD PLASTIC CONTAINER · 0.9 % · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01963937Code de médicament DPD
13286
|
|
10% DEXTRAN 40 IN 0.9% SODIUM CHLORIDE INJECTION · 0.9 % + 10 % · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01924206Code de médicament DPD
14249
|
|
10% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP · 10 G per 100 ML + 900 MG per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01927922Code de médicament DPD
12787
|
|
12 SELS DE SCHUESSLER · 6 DH · TABLET
|
DOLISOS CANADA INC. |
cancelled |
DIN
02236458Code de médicament DPD
55267
|
|
12% SODIUM CHLORDIE PROCESSING SOLUTION · 12 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00783625Code de médicament DPD
12168
|
|
1.6% SODIUM CHLORDIE PROCESSING SOLUTION · 1.6 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
00783633Code de médicament DPD
12169
|
|
(20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP · 150 MG per 100 ML + 900 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00786209Code de médicament DPD
9826
|
|
(20 MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 3.3 G per 100 ML + 150 MG per 100 ML + 300 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438014Code de médicament DPD
3132
|
|
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.2% SODIUM CHLORIDE INJECTION USP · 5 G per 100 ML + 150 MG per 100 ML + 200 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
00503142Code de médicament DPD
10043
|
|
(20MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP · 5 G per 100 ML + 450 MG per 100 ML + 150 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00437999Code de médicament DPD
10044
|
|
(20 MMOL/L) POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.9% SODIUM CHLORIDE INJECTION USP · 150 MG per 100 ML + 900 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00786292Code de médicament DPD
10866
|
|
20% SODIUM CHLORIDE INJECTION, BP · PHARMACY BULK · 20 % per W/V · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
02514184Code de médicament DPD
100335
|
|
23.4% SODIUM CHLORIDE INJECTION USP · 23.4 % · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
02245934Code de médicament DPD
70058
|
|
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE · 145 MG per 100 ML + 182.5 MG per 100 ML + 520 MG per 100 ML + 29.3 MG per 100 ML + 45 MG per 100 ML + 170 MG per 100 ML + 10 G per 100 ML + 10 MG per 100 ML + 105 MG per 100 ML + 150 MG per 100 ML + 100 MG per 100 ML + 125 MG per 100 ML + 120 MG per 100 ML + 130.5 MG per 100 ML + 140 MG per 100 ML + 25.5 MG per 100 ML + 260 MG per 100 ML + 290 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02143267Code de médicament DPD
20288
|
|
2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX · 120 MG per 100 ML + 45 MG per 100 ML + 110 MG per 100 ML + 520 MG per 100 ML + 260 MG per 100 ML + 105 MG per 100 ML + 145 MG per 100 ML + 10 G per 100 ML + 10 MG per 100 ML + 115 MG per 100 ML + 155 MG per 100 ML + 130.5 MG per 100 ML + 29.3 MG per 100 ML + 25.5 MG per 100 ML + 170 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02013975Code de médicament DPD
14069
|
|
2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX · 520 MG per 100 ML + 130.5 MG per 100 ML + 145 MG per 100 ML + 182.5 MG per 100 ML + 45 MG per 100 ML + 10 MG per 100 ML + 29.3 MG per 100 ML + 170 MG per 100 ML + 120 MG per 100 ML + 150 MG per 100 ML + 125 MG per 100 ML + 105 MG per 100 ML + 290 MG per 100 ML + 25 G per 100 ML + 260 MG per 100 ML + 140 MG per 100 ML + 100 MG per 100 ML + 25.5 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143259Code de médicament DPD
20272
|
|
2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX · 159.5 MG per 100 ML + 110 MG per 100 ML + 25 G per 100 ML + 570 MG per 100 ML + 154 MG per 100 ML + 201 MG per 100 ML + 165 MG per 100 ML + 283 MG per 100 ML + 115.5 MG per 100 ML + 112 MG per 100 ML + 51 MG per 100 ML + 187 MG per 100 ML + 261 MG per 100 ML + 215.5 MG per 100 ML + 49.5 MG per 100 ML + 11 MG per 100 ML + 316 MG per 100 ML + 137.5 MG per 100 ML + 132 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143232Code de médicament DPD
20274
|
|
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX · 126 MG per 100 ML + 115 MG per 100 ML + 570 MG per 100 ML + 170 MG per 100 ML + 215.5 MG per 100 ML + 159 MG per 100 ML + 285 MG per 100 ML + 120.5 MG per 100 ML + 112 MG per 100 ML + 49.5 MG per 100 ML + 261 MG per 100 ML + 131.5 MG per 100 ML + 11 MG per 100 ML + 51 MG per 100 ML + 25 G per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014009Code de médicament DPD
19608
|
|
2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX · 112 MG per 100 ML + 215.5 MG per 100 ML + 256 MG per 100 ML + 126 MG per 100 ML + 570 MG per 100 ML + 51 MG per 100 ML + 131.5 MG per 100 ML + 5 G per 100 ML + 159 MG per 100 ML + 170 MG per 100 ML + 285 MG per 100 ML + 49.5 MG per 100 ML + 11 MG per 100 ML + 115 MG per 100 ML + 120.5 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02013991Code de médicament DPD
14070
|
|
2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. · 159.5 MG per 100 ML + 154 MG per 100 ML + 51 MG per 100 ML + 215 MG per 100 ML + 5 G per 100 ML + 261 MG per 100 ML + 570 MG per 100 ML + 137.5 MG per 100 ML + 165 MG per 100 ML + 187 MG per 100 ML + 283 MG per 100 ML + 115.5 MG per 100 ML + 201 MG per 100 ML + 132 MG per 100 ML + 112 MG per 100 ML + 110 MG per 100 ML + 316 MG per 100 ML + 11 MG per 100 ML + 49.5 MG per 100 ML · LIQUID
|
CLINTEC NUTRITION COMPANY |
cancelled |
DIN
02143240Code de médicament DPD
20273
|
|
3.33% DEXTROSE AND 0.3% SODIUM CHLORIDE · 33.3 MG per ML + 3 MG per ML · SOLUTION
|
ICU MEDICAL CANADA INC |
cancelled |
DIN
00038881Code de médicament DPD
2575
|
|
3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 300 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
B. BRAUN MEDICAL INC |
authorised |
DIN
01927981Code de médicament DPD
12711
|
|
3% SODIUM CHLORIDE INJECTION USP · 30 MG per ML · LIQUID
|
B. BRAUN MEDICAL INC |
cancelled |
DIN
01924184Code de médicament DPD
21685
|
|
3 SULFA · 80000 UNIT per 450 G + 136.3 G per 450 G + 250 MG per 450 G + 200 MG per 450 G + 2.8 G per 450 G + 3.15 G per 450 G + 3 G per 450 G + 67.4 G per 450 G + 2.3 MG per 450 G + 700 MG per 450 G + 170.5 G per 450 G + 240000 UNIT per 450 G · POWDER FOR SOLUTION
|
BIO AGRI MIX LP |
cancelled |
DIN
02270072Code de médicament DPD
75547
|
|
3-SULVIT · 3.15 G per 450 G + 240000 UNIT per 450 G + 2.3 MG per 450 G + 102.9 G per 450 G + 80000 UNIT per 450 G + 250 MG per 450 G + 200 MG per 450 G + 67.4 G per 450 G + 3 G per 450 G + 170.5 G per 450 G + 761.9 MG per 450 G + 2.8 G per 450 G · POWDER FOR SOLUTION
|
BIO AGRI MIX LP |
cancelled |
DIN
00511757Code de médicament DPD
3926
|
|
(40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP · 900 MG per 100 ML + 300 MG per 100 ML · LIQUID
|
BAXTER CORPORATION |
authorised |
DIN
00786217Code de médicament DPD
9827
|
|
(40MMOL/L) POTASSIUM CHLORIDE IN 3.3% DEXTROSE AND 0.3% SODIUM CHLORIDE INJECTION USP · 300 MG per 100 ML + 3.3 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438022Code de médicament DPD
3133
|
|
(40MMOL/L)POTASSIUM CHLORIDE IN 5% DEXTROSE AND 0.45% SODIUM CHLORIDE INJECTION USP · 450 MG per 100 ML + 300 MG per 100 ML + 5 G per 100 ML · SOLUTION
|
BAXTER CORPORATION |
authorised |
DIN
00438006Code de médicament DPD
10045
|
|
(40 MMOLS/L) POTASSIUM CHLORIDE IN LACTATED RINGER'S INJECTION USP · 20 MG per 100 ML + 600 MG per 100 ML + 328 MG per 100 ML + 310 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION |
cancelled |
DIN
02246134Code de médicament DPD
70277
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE · 246.5 MG per 100 ML + 76.5 MG per 100 ML + 10 G per 100 ML + 77 MG per 100 ML + 51 MG per 100 ML + 17 MG per 100 ML + 212.5 MG per 100 ML + 297 MG per 100 ML + 489 MG per 100 ML + 289 MG per 100 ML + 261 MG per 100 ML + 178.5 MG per 100 ML + 204 MG per 100 ML + 170 MG per 100 ML + 310 MG per 100 ML + 880 MG per 100 ML + 238 MG per 100 ML + 255 MG per 100 ML + 438 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142414Code de médicament DPD
20276
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE · 20 G per 100 ML + 51 MG per 100 ML + 246.5 MG per 100 ML + 204 MG per 100 ML + 297 MG per 100 ML + 238 MG per 100 ML + 289 MG per 100 ML + 489 MG per 100 ML + 310 MG per 100 ML + 255 MG per 100 ML + 17 MG per 100 ML + 178.5 MG per 100 ML + 170 MG per 100 ML + 76.5 MG per 100 ML + 77 MG per 100 ML + 212.5 MG per 100 ML + 438 MG per 100 ML + 261 MG per 100 ML + 880 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142406Code de médicament DPD
20277
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX · 297 MG per 100 ML + 261 MG per 100 ML + 263 MG per 100 ML + 186 MG per 100 ML + 17 MG per 100 ML + 178 MG per 100 ML + 880 MG per 100 ML + 77 MG per 100 ML + 203 MG per 100 ML + 76 MG per 100 ML + 20 G per 100 ML + 246 MG per 100 ML + 440 MG per 100 ML + 195 MG per 100 ML + 51 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02014033Code de médicament DPD
19609
|
|
4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE · 17 MG per 100 ML + 438 MG per 100 ML + 25 G per 100 ML + 246.5 MG per 100 ML + 297 MG per 100 ML + 880 MG per 100 ML + 76.5 MG per 100 ML + 170 MG per 100 ML + 310 MG per 100 ML + 261 MG per 100 ML + 212.5 MG per 100 ML + 238 MG per 100 ML + 178.5 MG per 100 ML + 489 MG per 100 ML + 51 MG per 100 ML + 289 MG per 100 ML + 255 MG per 100 ML + 204 MG per 100 ML + 77 MG per 100 ML · SOLUTION
|
BAXTER CORPORATION CLINTEC NUTRITION DIVISION |
cancelled |
DIN
02142392Code de médicament DPD
20292
|